glp-1 kidney pain receptor agonists in patients with chronic disease and either overweight or obesity GLP-1 therapy is changing the

Some people genetically produce lower levels of natural GLP hormones, meaning they do not sense when they are full, and end up binge eating, says Kim Dennis , a psychiatrist and CEO of SunCloud Health treatment center in Chicago

[DOI] [PMC free article] [PubMed] [Google Scholar] Rutz C, Renner A, Alken M, Schulz K, Beyermann M, Wiesner B, Rosenthal W, Schlein R

They might not only be beneficial for GLP1R LoF carriers but also for obese and diabetics patients that are either resistant to current GLP1R agonists treatments or are suffering from serious adverse effects

View image online ( woman injecting GLP-1 shot This article is republished from the Cleveland Clinic Journal of Medicine

Theres really nothing surprising about it, and theres nothing to be alarmed about this